51

Introduction: Presentation of viral antigens to cytotoxic T cells

Year:
1996
Language:
english
File:
PDF, 27 KB
english, 1996
53

How does HTLV-I persist despite a strong cell-mediated immune response?

Year:
2008
Language:
english
File:
PDF, 621 KB
english, 2008
55

AIDS: the evolving story

Year:
2000
Language:
english
File:
PDF, 102 KB
english, 2000
58

HTLV-1 infection: what determines the risk of inflammatory disease?

Year:
2012
Language:
english
File:
PDF, 284 KB
english, 2012
60

What is required of an HIV vaccine?

Year:
1997
Language:
english
File:
PDF, 218 KB
english, 1997
63

Cell-Mediated Immune Response to Human T-Lymphotropic Virus Type I

Year:
2005
Language:
english
File:
PDF, 220 KB
english, 2005
72

Ginkgo biloba

Year:
2014
Language:
english
File:
PDF, 263 KB
english, 2014
75

Modification of acipimox's licensed uses

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
76

Magnesium hydroxide overdose

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
80

Crizotinib

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
83

Paracetamol

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
85

Bortezomib

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
89

Adalimumab

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
94

Clonality, latency and integration of HTLV-1in vivo

Year:
2013
Language:
english
File:
PDF, 67 KB
english, 2013
97

Human T-cell leukaemia virus type I and neurological disease

Year:
1993
Language:
english
File:
PDF, 910 KB
english, 1993
100

Defective interfering particles and virus evolution

Year:
1993
Language:
english
File:
PDF, 555 KB
english, 1993